Index RUT
P/E -
EPS (ttm) -0.02
Insider Own 68.15%
Shs Outstand 114.87M
Perf Week -0.94%
Market Cap 363.48M
Forward P/E 121.72
EPS next Y 0.03
Insider Trans -0.05%
Shs Float 36.75M
Perf Month -14.86%
Income -2.39M
PEG -
EPS next Q -0.09
Inst Own 26.12%
Short Float 3.39%
Perf Quarter 29.10%
Sales 566.49M
P/S 0.64
EPS this Y -148.93%
Inst Trans -2.15%
Short Ratio 5.45
Perf Half Y 31.80%
Book/sh 3.48
P/B 0.91
EPS next Y 136.09%
ROA -0.28%
Short Interest 1.24M
Perf Year 35.19%
Cash/sh 0.89
P/C 3.54
EPS next 5Y -5.70%
ROE -0.61%
52W Range 2.04 - 4.77
Perf YTD 19.77%
Dividend Est. -
P/FCF 4.37
EPS past 5Y -
ROI -0.34%
52W High -33.96%
Beta 1.61
Dividend TTM -
Quick Ratio 1.64
Sales past 5Y 18.73%
Gross Margin 22.32%
52W Low 54.79%
ATR (14) 0.21
Dividend Ex-Date -
Current Ratio 2.77
EPS Y/Y TTM 57.09%
Oper. Margin 3.67%
RSI (14) 43.46
Volatility 5.34% 5.99%
Employees 1760
Debt/Eq 0.84
Sales Y/Y TTM -18.58%
Profit Margin -0.42%
Recom 2.25
Target Price 3.60
Option/Short Yes / Yes
LT Debt/Eq 0.77
EPS Q/Q 100.59%
Payout -
Rel Volume 0.38
Prev Close 3.19
Sales Surprise 4.51%
EPS Surprise 153.20%
Sales Q/Q -15.80%
Earnings May 07 AMC
Avg Volume 228.33K
Price 3.15
SMA20 -9.86%
SMA50 -2.95%
SMA200 4.73%
Trades
Volume 86,810
Change -1.25%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-18-24 Upgrade
Stifel
Hold → Buy
$3 → $4
Mar-13-24 Downgrade
BofA Securities
Buy → Underperform
$4.50 → $2.60
Dec-14-22 Downgrade
Barclays
Overweight → Equal Weight
$7 → $5
Dec-13-22 Initiated
Stifel
Hold
$3
Jul-13-22 Downgrade
Goldman
Neutral → Sell
$8 → $5.50
Nov-11-21 Upgrade
BofA Securities
Neutral → Buy
$18 → $27
Nov-08-21 Initiated
BofA Securities
Neutral
$18
May-18-21 Initiated
Wolfe Research
Outperform
$38
May-18-21 Initiated
William Blair
Outperform
May-18-21 Initiated
Truist
Buy
May-18-21 Initiated
Robert W. Baird
Outperform
$36
May-18-21 Initiated
Morgan Stanley
Equal-Weight
$33
May-18-21 Initiated
KeyBanc Capital Markets
Overweight
$38
May-18-21 Initiated
Goldman
Neutral
$26
May-18-21 Initiated
Barclays
Overweight
$37
Show Previous Ratings
Apr-22-24 02:45AM
Apr-19-24 04:20AM
Apr-10-24 04:15PM
04:52AM
Apr-02-24 05:34AM
11:59AM
Loading…
Mar-18-24 11:59AM
Mar-13-24 12:55PM
12:17PM
09:08AM
06:57AM
(Thomson Reuters StreetEvents)
Mar-12-24 05:33PM
04:13PM
04:05PM
Mar-07-24 11:57AM
07:41AM
08:30AM
Loading…
Feb-13-24 08:30AM
Nov-13-23 11:22AM
08:00AM
Nov-08-23 03:21AM
(Thomson Reuters StreetEvents) -10.46%
Nov-07-23 08:19AM
07:17AM
(Associated Press Finance)
07:00AM
Nov-01-23 04:30PM
09:15AM
Oct-31-23 10:01AM
Oct-24-23 08:00AM
Oct-17-23 07:00AM
Oct-11-23 12:53PM
Sep-30-23 09:42AM
Aug-22-23 01:01PM
01:03AM
Loading…
Aug-09-23 01:03AM
(Thomson Reuters StreetEvents)
Aug-08-23 08:50AM
07:40AM
(Associated Press Finance)
07:00AM
Aug-03-23 08:55AM
Jul-26-23 07:49AM
Jul-18-23 07:00AM
Jul-14-23 04:18PM
Jun-29-23 06:30AM
Jun-13-23 08:30AM
Jun-09-23 07:19AM
May-26-23 07:00AM
May-23-23 07:00AM
May-15-23 06:07AM
(Simply Wall St.) +11.11%
May-10-23 06:18AM
02:22AM
(Thomson Reuters StreetEvents)
May-09-23 08:45AM
07:40AM
07:00AM
Apr-18-23 11:12AM
07:00AM
Mar-31-23 07:00AM
Mar-10-23 05:26AM
(Simply Wall St.) -10.99%
Mar-08-23 03:32AM
(Thomson Reuters StreetEvents)
Mar-07-23 08:25AM
07:00AM
Feb-16-23 06:25AM
Feb-14-23 07:00AM
Feb-08-23 10:50AM
Jan-26-23 08:04AM
Jan-20-23 02:36PM
(American City Business Journals)
10:04AM
05:18AM
Jan-19-23 04:05PM
Dec-30-22 02:26PM
Dec-10-22 08:25AM
Nov-30-22 04:29PM
Nov-13-22 07:57AM
Nov-12-22 07:53AM
Nov-11-22 12:53PM
(American City Business Journals)
Nov-10-22 08:25AM
07:00AM
Nov-07-22 12:36PM
Nov-03-22 10:00AM
Oct-28-22 10:53AM
Oct-26-22 12:12PM
Oct-20-22 07:00AM
Oct-17-22 10:07AM
Oct-14-22 11:38AM
(American City Business Journals)
Sep-16-22 11:17AM
Sep-01-22 06:15AM
Aug-31-22 07:00AM
Aug-11-22 07:00PM
08:25AM
07:00AM
Aug-09-22 04:05PM
Aug-02-22 09:04AM
Jul-22-22 07:23AM
Jul-21-22 07:00AM
Jul-06-22 04:16PM
10:02AM
Jun-24-22 01:38PM
Jun-14-22 07:30AM
May-31-22 10:27AM
May-27-22 07:00AM
May-12-22 05:00PM
08:35AM
07:00AM
May-05-22 09:55AM
Apr-22-22 11:40AM
Latham Group, Inc. operates as a designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. It offers a portfolio of pools and related products, including in-ground swimming pools, pool liners, and pool covers. The company was founded on December 6, 2018 and is headquartered in Latham, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Gloe Oliver C. CHIEF FINANCIAL OFFICER Mar 15 '24 Buy 2.92 27,500 80,300 292,922 Mar 19 05:50 PM Rajeski Scott Michael CHIEF EXECUTIVE OFFICER Mar 04 '24 Sale 3.05 24,913 75,985 266,143 Mar 05 06:43 PM Cowley Joshua D. CHIEF COMMERCIAL OFFICER Mar 04 '24 Sale 3.05 14,650 44,682 193,036 Mar 05 06:42 PM Sheller Patrick M GENERAL COUNSEL & SECRETARY Mar 04 '24 Sale 3.05 10,431 31,815 139,164 Mar 05 06:40 PM Bahl Sanjeev CHIEF OPERATING OFFICER Mar 04 '24 Sale 3.05 10,342 31,543 126,713 Mar 05 06:41 PM Dhruv Kaushal Bhikhesh CHIEF INFORMATION OFFICER Mar 04 '24 Sale 3.05 6,531 19,920 242,142 Mar 05 06:43 PM Kunchala Suraj VICE PRESIDENT & CONTROLLER Mar 04 '24 Sale 3.05 2,166 6,606 24,899 Mar 05 06:39 PM Rajeski Scott Michael CHIEF EXECUTIVE OFFICER Aug 22 '23 Buy 3.96 8,000 31,680 291,056 Aug 22 04:57 PM Rajeski Scott Michael CHIEF EXECUTIVE OFFICER Aug 18 '23 Buy 4.00 12,000 48,000 283,056 Aug 21 06:15 PM Feck Melissa Claire CHIEF HUMAN RESOURCES OFFICER Aug 11 '23 Sale 4.19 7,167 30,058 446,167 Aug 11 08:18 PM Rajeski Scott Michael CHIEF EXECUTIVE OFFICER Aug 10 '23 Buy 4.08 13,000 53,024 271,056 Aug 11 08:16 PM Feck Melissa Claire CHIEF HUMAN RESOURCES OFFICER Aug 10 '23 Sale 4.05 92,833 376,224 453,334 Aug 11 08:18 PM Sheller Patrick M GENERAL COUNSEL & SECRETARY Aug 09 '23 Sale 4.40 3,968 17,459 149,595 Aug 10 09:26 AM BORSETH J MARK INTERIM CFO Jul 25 '23 Sale 3.94 39,035 153,739 819,767 Jul 25 08:44 PM Cline James E Director May 12 '23 Buy 3.40 10,000 34,000 169,050 May 12 07:24 PM Cline James E Director May 11 '23 Buy 3.40 40,000 136,000 159,050 May 12 07:24 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite